Oriken Pharmaceuticals Private Limited

Oriken Pharmaceuticals Private Limited - pharma in Keonjhar, Odisha, India. FY 2026 financials & compliance.
CIN U24100OR2019PTC030187 Incorporated 07 January 2019 ROC Cuttack HQ Keonjhar, Odisha, India
Active Private Limited Company pharma
Data last updated
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Last financials
Mar 2023
Balance sheet date
Last AGM
30 Sep 2023
Annual general meeting
Company status
Active
MCA master data
Registrar
Cuttack
ROC office

About Oriken Pharmaceuticals Private Limited

Data last updated:

Oriken Pharmaceuticals Private Limited is a private limited company based in Keonjhar, Odisha, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 January 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24100OR2019PTC030187.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sailesh Chandra Sahoo and Subrat Kumar Sahoo.

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No.225/959 Sponge Colony Po/Ps – Keonjhar Jagannathpur Kasipur, Odisha, India – 758001.

Company details

CIN U24100OR2019PTC030187
Registration Number 030187
Incorporation Date 07 January 2019
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023

Contact details

Oriken Pharmaceuticals Private Limited's registered office is in Keonjhar, Odisha. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No.225/959 Sponge Colony Po/Ps – Keonjhar Jagannathpur Kasipur, Odisha, India – 758001
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Oriken Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Oriken Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Oriken Pharmaceuticals Private Limited

FY 2023 filings available

Financial Statement Summary

MetricsFY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Oriken Pharmaceuticals Private Limited, buy the company report.

Board of directors of Oriken Pharmaceuticals Private Limited

Oriken Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sailesh Chandra SahooDirector07 Jan 20197 Years 9 MonthsCurrent
Subrat Kumar SahooDirector07 Jan 20197 Years 9 MonthsCurrent

Auditor

Oriken Pharmaceuticals Private Limited is audited by G N S & ASSOCIATES for the financial year 2020.

Auditor firmFinancial yearFirm registration number
G N S & ASSOCIATESFY 2020318171E

Shareholding

The shareholding of Oriken Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2020
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Oriken Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Oriken Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Oriken Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Oriken Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Sailesh Chandra Sahoo was appointed as Director on 07 Jan 2019.

AGM
Oriken Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Oriken Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Cuttack.
Appointed
Sailesh Chandra Sahoo was appointed as Director.
Appointed
Subrat Kumar Sahoo was appointed as Director.
Incorporation
07 Jan 2019
Oriken Pharmaceuticals Private Limited was registered on 07 Jan 2019 with Roc Cuttack & aged 7 years 9 months as per MCA records.

Frequently asked questions

Oriken Pharmaceuticals is an active private limited company based in Keonjhar, Odisha, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 January 2019 (7+ years old) and is registered under CIN U24100OR2019PTC030187.

Oriken Pharmaceuticals has 2 current directors:

The latest financial statements of Oriken Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.

The CIN (Corporate Identification Number) of Oriken Pharmaceuticals is U24100OR2019PTC030187. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Oriken Pharmaceuticals was incorporated on 07 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Cuttack.

Sailesh Chandra Sahoo was appointed as Director on 07 Jan 2019. Subrat Kumar Sahoo was appointed as Director on 07 Jan 2019.

The registered office of Oriken Pharmaceuticals is at Plot No.225959 Sponge Colony PoPs – Keonjhar Jagannathpur Kasipur, Odisha, India – 758001.

Oriken Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

Oriken Pharmaceuticals can be reached at its registered office: Plot No.225959 Sponge Colony PoPs – Keonjhar Jagannathpur Kasipur, Odisha, India – 758001.

Oriken Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Cuttack.